Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
Horizon Lines: A Quarterly Review of NDAs – October- December 2025
This quarterly review of New Drug Applications contains data for applications approved for the first time during the last quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 40 applications were approved by the FDA during these three months. read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Altasciences Expands Harleysville R&D Lab to Strengthen Early-Stage CDMO Services
Thursday, August 06, 2026
Altasciences has completed an expansion of the research and development laboratory at its drug product formulation and manufacturing facility in ... read more
Clinilabs Names Dagher CMO, Siddiqui Principal Investigator
Wednesday, August 05, 2026
Clinilabs has appointed Bob Dagher, M.D., as chief medical officer and Waqar Ahmed Siddiqui, M.D., as principal investigator at its Eatontown, New ... read more
Porton Advanced Wins Class C License to Expand CGT Manufacturing Into Commercial Stage
Wednesday, August 05, 2026
Porton Advanced Solutions has secured a Drug Manufacturing License (Class C) from China’s National Medical Products Administration, a milestone that ... read more
Altruist Biologics Completes First Commercial PPQ at Hangzhou Site
Wednesday, August 05, 2026
Altruist Biologics has completed the first commercial process performance qualification campaign for its 20,000L stainless steel bioreactors at its ... read more
Piramal Pharma Solutions Expands Turbhe Peptide Facility With New Spray Drying Suite
Tuesday, August 04, 2026
Piramal Pharma Solutions has expanded its peptide API facility in Turbhe, India, with a new spray drying suite designed to support challenging ... read more